DPM2 Serve as Novel Oncogene and Prognostic Marker Transactivated by ESR1 in Breast Cancer

Researchers uncovered the tumorigenic and prognostic role of dolichyl-phosphate mannosyltransferase subunit 2 (DPM2) in breast cancer, cellular assays, and bioinformatics analysis highlighted DPM2 as oncogene via inhibited cancer-related signaling pathways in breast cancer.